Sektor Macro Group Pharmaceuticals (Macro Capital) S.A.E

Aktien

MCRO

EGS7D971C011

MCRO

Pharmazeutika

Schlusskurs Egyptian Exchange 28.07.2026 % 5 Tage Veränd. 1. Jan.
1.530 EGP +2.68% Intraday Chart für Macro Group Pharmaceuticals (Macro Capital) S.A.E +9.29% +34.21%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
+2.68%+9.29%+29.66%+29.66%+34.21%-25.37%-43.33% - - 16.75 Mio.
+1.93%+3.85%+1.04%+39.66%+13.58%+51.05%+166.24%+395.18%+1’371.92% 1’068 Mrd.
+0.29%+6.43%+4.74%+17.09%+28.89%+60.47%+52.87%+54.91%+114.31% 641 Mrd.
+2.45%+2.77%+3.89%+33.14%+15.19%+39.61%+74.48%+122.02%+306.67% 454 Mrd.
+2.17%+10.22%+9.49%+14.57%+12.10%+41.17%+36.56%+5.84%+49.86% 351 Mrd.
+1.46%+3.87%+3.26%+13.67%+18.98%+39.70%+44.49%+55.28%+62.39% 299 Mrd.
+0.40%+3.59%-9.62%-6.91%-6.16%+19.93%+17.02%+56.54%+157.41% 266 Mrd.
+2.73%+3.50%+5.49%+26.49%+3.12%-25.66%-36.53%+16.70%+77.51% 220 Mrd.
+4.48%+7.33%+9.70%+15.76%+20.10%+30.47%+66.31%+60.94%+129.51% 203 Mrd.
+2.91%+3.10%+5.04%+3.91%+9.43%+18.84%+74.76%+91.72%+65.34% 162 Mrd.
+2.35%+1.24%+3.95%-4.65%+1.41%+3.87%-30.00%-41.89%-31.14% 141 Mrd.
+1.66%+4.38%+10.57%+9.17%+17.91%+33.87%+3.57%-7.46%-14.81% 128 Mrd.
+2.38%+1.74%-0.19%+14.01%+8.17%+6.41%+38.51%+142.48%+409.71% 122 Mrd.
+2.04%+3.43%+5.74%+0.62%-4.04%-7.16%-16.41%-9.37%+4.05% 106 Mrd.
+3.47%+7.18%+2.32%+0.05%+11.21%+45.14%+46.71%+15.81%-4.49% 104 Mrd.
+0.54%-3.71%-7.12%-13.32%-14.65%-4.61%+66.27%+71.54%+446.05% 68.84 Mrd.
-.--%+1.73% - - - - - - - 63.66 Mrd.
+2.40%+5.93%+13.62%+11.59%+21.63%+37.21%+35.48%+56.58%+28.18% 56.28 Mrd.
-0.42%-1.24%+0.06%+28.43%+27.07%+62.42%-10.25%-6.91%-50.13% 52.78 Mrd.
-0.58%-2.99%+9.49%-2.83%-10.54%-14.10%+8.64%-4.69%+227.97% 52.23 Mrd.
Durchschnitt +1.79%+2.98%+5.32%+12.11%+10.93%+21.75%+31.34%+59.73%+186.13% 227.87 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +1.90%+4.13%+3.37%+19.75%+13.30%+35.69%+67.63%+132.57%+421.59%
Pharmazeutika - Andere
  1. Börse
  2. Aktien
  3. MCRO Aktie
  4. Sektor Macro Group Pharmaceuticals (Macro Capital) S.A.E